Antilipolysis as a tool in the study of clinical and experimental diabetes. Lecture for the 1968 Minkowski Award.
D000138:Acidosis / Q000097:blood; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism*; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008053:Lipid Mobilization / Q000187:drug effects*; D008055:Lipids / Q000037:antagonists & inhibitors* / Q000097:blood*; D009539:Nicotinic Acids / Q000494:pharmacology*
D005230:Fatty Acids, Nonesterified; D006885:Hydroxybutyrates; D000960:Hypolipidemic Agents; D008055:Lipids; D009539:Nicotinic Acids; D000242:Cyclic AMP